RNAi

In a reader survey, researchers and core lab staff share how they think cores are doing.

To Interfere

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.

Researchers from the Broad Institute and Novartis used RNA interference to generate catalogs of genes that cancer cells rely on to grow and survive.

The US Environmental Protection Agency has approved an RNAi-based insecticide, according to the Atlantic.

Researchers described the development and testing of layered double hydroxide nanosheets as carriers for RNAi molecules in agriculture.

A Little Spritz

An Australian team has developed a method to spray double-stranded RNA on plants to make them resistant to pests, Technology Review reports.

The researchers said their one-step, inducible, multiplex gene knockdown and gene knockout platforms can be used in many differentiated cell types.

This Week in PLOS

In PLOS this week: sites in dog genome under selection during early domestication, tuberculosis transmission patterns, and more.

By comparing Cryptococcus genomes, Duke researchers found that C. deuterogattii lacks certain RNAi pathway genes, possibly contributing to its high virulence.

Pages

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.